PCA
LH icon

Pallas Capital Advisors’s Labcorp LH Stock Holding History

Pallas Capital Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-889
Closed -$237K – 1070
2026
Q1 		$237K Sell
889
-660
-43% -$179K 0.01% 708
2025
Q4 		$389K Sell
1,549
-53
-3% -$14.1K 0.01% 604
2025
Q3 		$460K Buy
1,602
+19
+1% +$5.09K 0.02% 540
2025
Q2 		$416K Sell
1,583
-375
-19% -$91.3K 0.02% 561
2025
Q1 		$456K Buy
1,958
+30
+2% +$7.28K 0.02% 495
2024
Q4 		$442K Buy
1,928
+5
+0.3% +$1.15K 0.02% 390
2024
Q3 		$442K Buy
1,923
+328
+21% +$72.1K 0.02% 384
2024
Q2 		$342K Buy
+1,595
New +$324K 0.02% 384
2024
Q1 		– Sell
-4,980
Closed -$1.13M – 444
2023
Q4 		$1.13M Buy
+4,980
New +$1.05M 0.06% 197
2022
Q1 		– Sell
-1,490
Closed -$348K – 265
2021
Q4 		$348K Sell
1,490
-1,261
-46% -$312K 0.04% 230
2021
Q3 		$679K Buy
+2,751
New +$693K 0.07% 191

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pallas Capital Advisors's LH Position: Q2 2026 in Review

Pallas Capital Advisors sold out of Labcorp (LH) in Q2 2026, closing a stake of 889 shares — an estimated $237K sold.

Pallas Capital Advisors first reported a position in LH in Q3 2021 and held it in 11 quarters. The position peaked at $1.13M in Q4 2023. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Pallas Capital Advisors reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Pallas Capital Advisors sold 889 Labcorp shares in Q2 2026, an estimated $237K.
  • Pallas Capital Advisors first reported a position in Labcorp in Q3 2021 and held it in 11 quarters.
  • Pallas Capital Advisors's Labcorp position peaked at $1.13M in Q4 2023.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.